Breaking news – Pagina 175 – AMD

Breaking news

Ottobre 20, 2023 dario.olivero

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial

Russell-Jones D, Babazono T, Cailleteau R, et al.
The Lancet. Pub. online 17 Oct 2023.

Leggi

Ottobre 20, 2023 dario.olivero

CamAPS FX hybrid closed-loop with ultra-rapid lispro compared with standard lispro in adults with type 1 diabetes: a double-blind, randomized, crossover study

Nwokolo M, Lakshman R, Hartnell S, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2023.

Leggi

Ottobre 16, 2023 dario.olivero

Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy

Lawton J, Kimbell B, Closs M, et al.
Diabetes Technol Ther. Pub. online 5 Oct 2023.

Leggi

Ottobre 16, 2023 dario.olivero

Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial

Nørgaard SK, Søholm JC, Mathiesen ER, et al.
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00236-X.

Leggi

Ottobre 16, 2023 dario.olivero

Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction

Butt JH, Docherty KF, Kosiborod MN, et al.
J Am Coll Cardiol HF. 2023, 11 (10) 1411–1423.

Leggi

Ottobre 16, 2023 dario.olivero

A european cost-utility analysis of the MiniMed^TM 780g advanced hybrid closed-loop system versus intermittently scanned continuous glucose monitoring with multiple daily insulin injections in people living with type 1 diabetes

Jendle J, Buompensiere MI, Saltik AZO, et al.
Diabetes Technol Ther. Pub. online 6 Oct 2023.

Leggi

Ottobre 16, 2023 dario.olivero

Precision medicine of obesity as an integral part of type 2 diabetes management – past, present, and future

Szczerbinski L, Florez JC
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00232-2.

Leggi

Ottobre 16, 2023 dario.olivero

Semaglutide effects according to ejection fraction in heart failure with preserved ejection fraction and obesity

Butler J, Abildstrøm SZ, Borlaug BA, et al.
J Am Coll Cardiol. Pub. online 08 Oct 2023.

Leggi

Ottobre 9, 2023 dario.olivero

Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes

Sridhar VS, Limonte CP, Groop PH, et al.
Diabetologia. Pub. online 6 Oct 2023.

Leggi

Ottobre 9, 2023 dario.olivero

Comparison of intranasal and injectable glucagon administration among pediatric population responders

Wang YP, Bernatchez F, Chouinard-Castonguay S, et al.
Diabetes Technol Ther. Pub. online 26 Sep 2023.

Leggi